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Abstract
Background: To develop a novel preimplantation genetic screening (PGS) test using next generation sequencing(NGS)
as a alternative to current array comparative genomic hybridization (array CGH) method for detection of small segmental
translocations in two patients with repeated implantation failure (RIF) and recurrent miscarriage (RM). Inconsistent results
were resolved by validation with fluorescence in situ hybridization (FISH).
Case Presentation: One couple with normal cytogenetic and array CGH result suffered from implantation failure. Later
NGS analysis showed 46,XY.ngs[GRCh37/hg19] 9p24.3-9p24.1(10,291-8,680,890×1),13q33.1-13q34(103,046,327-
114,785,444×3). The other couple with normal cytogenetic and array CGH result also received NGS analysis. Due to the
detected abnormal finding, which was 46,XY.ngs 4q34.3-4q35.2(179,673,982-191,016,503×3),6p25.3-6p22.3 (146,672-
17,829,693×1), the couple decided against the corresponding embryo transfer.
Conclusions: The NGS approach is a reliable alternative to array CGH for the discovery of small segmental translocations
in patients with RIF and RM.
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Background
Repeated implantation failure (RIF) usually refers to fail-
ure of transferred embryos to implant following at least
three in vitro fertilization (IVF) treatment cycles, in
which 1–2 embryos of high grade quality are transferred
in each cycle [1, 2]. Abnormal embryo, endometrium or
immune system will result in implantation failure.
Therefore, in assessing RIF, the embryo should be evalu-
ated for potential abnormality [3]. Recurrent miscarriage
(RM) is defined as two or more miscarriage [4]. Etiologic
factors can be identified in approximately 50 % of these
couples. Preimplantation genetic screening (PGS) was
proposed for couples with unexplained RM and RIF be-
cause aneuploidy of the embryo may cause RM and RIF
[5–7].
Currently comparative genomic hybridization (array
CGH) techniques have been used for PGS to analyzing
metaphase II oocytes and their polar bodies, cleavage
stage embryos, and blastocysts [8, 9]. PGS by array CGH
with single euploid blastocyst transfer has been success-
fully applied in patients with RIF [10]. However, small
segmental structure abnormalities of the chromosomes
are sometimes not picked up in the currently available
commercial array CGH due to insufficient resolution
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[11, 12], degraded DNA from apoptosis [13], whole gen-
ome amplification (WGA) bias [14] and no specific
chromosomal abnormalities detected before induction
on PGS.
Next generation sequencing (NGS) was introduced for
PGS recently [15]. In retrospective and blind validation
studies, a high concordance between NGS and array
CGH for the same WGA products has been demon-
strated on aneuploidy screening. What is more, NGS
can correct the potential bias caused by WGA and is
therefore more accurate in detecting chromosomal
structural abnormality of small fragments [16]. Here, we
used NGS to reanalyze the biopsied samples with normal
result of array CGH analysis in two patients with RIF
and RM after PGS. To the best of our knowledge, this is
the first report of abnormal NGS results in RIF and RM




The couple has suffered spontaneous abortion for three
times from 2008 to 2009. Giemsa (G) banding karyotyp-
ing of 400 bands showed no obvious structural abnor-
mality for both. In vitro fertilization and embryo transfer
(IVF-ET) treatment was done in our hospital in July
2012. The first fresh cycle transplantation with two
embryos did not achieve pregnancy. Then frozen embryo
recovery transplantation (FET) was performed with two
embryos in December 2012. Spontaneous abortion
occurred after 7 weeks’ pregnancy. In August 2013, FET
was performed again. However, no blastocyst was formed
after frozen embryos were cultured. In September 2013,
array CGH PGS was used for screening embryos. One nor-
mal embryo was transferred in July 2014 but the pregnancy
test was negative. In February 2015, fifth spontaneous
abortion occurred again 70 days after natural conception.
Products of fifth abortion were analyzed by using multiple
connected probe amplification technology (MLPA) on
DNA extracted from fetal tissues. The remaining DNA
sample used for PGS by array CGH analysis was also
reanalyzed by NGS in May 2015.
Case 2
The couple received assisted reproductive technology
(ART) treatment in October 2011 because of primary
infertility for 5 years. G banding karyotyping of 400
bands showed no obvious structural abnormality of
this couple. Two embryos were transplanted in two
FET cycles in March and June 2012 respectively
without pregnancy. In November 2012, the third FET
was performed. Although pregnancy was achieved,
spontaneous abortion occurred after 2 months. In
November 2013, the forth FET was performed.
Against spontaneous abortion occurred after 57 days.
In January 2015, PGS by array CGH was performed
and two embryos were found to be normal, in May
2015, the NGS was used to analyze the remaining
DNA sample used in array CGH.
Karyotyping
Karyotyping was performed using peripheral blood from
the couples. Metaphase chromosomes were investigated
by G banding with at least 20 metaphases analyzed for
each patient.
Embryo culture and biopsy
All patients used a long protocol, or a GnRH
(Gonadotropin-releasing hormone) antagonist protocol
for controlled ovarian hyperstimulation. Oocytes were
retrieved 34 to 35 h after hCG injection and fertilized
with ICSI as previously described [17]. All embryos were
cultured in vitro in 20 ul microdrops of G1 culture
medium (Vitrolife), and on day 3 post of fertilization,
they were transferred to 20ul microdrops of G2 (Vitro-
life) to blastocysts stage under standard incubation con-
ditions. All embryos were cultured to the blastocyst
stage and scored according to Gardner’s grading scale
on day 5 after fertilization. Zona drilling for blastocyst
trophectoderm biopsy was performed on the morning of
Day 5 using the ZILOS-tk laser (Hamilton Thorne Bio-
sciences). Blastocysts were incubated for a further 4–6 h
to allow blastocoele expansion and extrusion of the
trophectoderm cells from the zona drilling hole. Blasto-
cyst biopsy performed within 10ul microdrops of Qunnis
Advantage Medium wtih HEPES (SAGE) add with 5 %
Human Serum Albumin (SAGE). Suction with the
biopsy pipette (Origio) and laser drilling were applied to
dissect four to five trophectoderm cells from the blasto-
cysts. The biopsied cells were rinsed three time with
G-MOPS (Vitrolife) medium and transfered to
RNAse–DNAse-free PCR tubes (Axygen) with the
minimum medium.
Whole genome amplification (WGA)
The biopsied trophectoderm cells, pooled single cell
DNA and negative control were subject to WGA using
single cell SurePlex WGA Kit (BlueGnome). This kit in-
cluded three steps of fragmentation (lysis), library prep-
aration and amplification. This WGA method is based
on random fragmentation of genomic DNA and conver-
sion of the resulting small fragments to PCR-amplifiable
library molecules flanked by universal priming sites.
Amplification products were stored at –20 °C. To avoid
contamination, this process should be all handled in a
ventilation cabinet.
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Array comparative genomic hybridization (Array-CGH)
Array-CGH was performed using oligonucleotide-based
custom arrays (8 × 60 K) (Agilent Tech), according to
the protocol of Agilent oligonucleotide array-based CGH
for single cell analysis (Agilent Tech) and scanning on
Agilent microarray scanner. Then Agilent feature extrac-
tion used for data interpretation and Agilent Genomic
Workbench 7.0/CytoGenomics v2.9 used for analysis.
Next generation sequencing (NGS)
ION XPRESS LIBRARY kit (Life Tech) was used to con-
struct the sequencing library. A total of 100 ng of WGA
products were incubated in the buffer and enzyme mix
II (Ion Shear™Plus) at 37 °C for 35 min for fragmenting.
DNA was purified by using Agencourt®AMPure®XP
beads (BeckMan) and connected with Ion Xpress™Bar-
code 1(Life Tech). The amplified libraries were run on
an E-Gel®SizeSelect™ 2 % agarose gel (Invitrogen) and
the fraction corresponding to a 200 bp insert was puri-
fied with AMPure beads (Agencourt). All samples were
diluted and used as a template for amplification using
the Ion OneTouch system (Ion PGMTMTemplate OT2
200 Kit, Life Technologies). Sample enrichment was per-
formed on the Ion OneTouch ES module and Ion 316
chips were used for sequencing. Data were analyzed
using the E&S System developed by Peking Jabrehoo
Med Tech., Ltd (Beijing, China), providing the percent-
age of DNA sequence reads mapped to each chromo-
some. In brief, the method splits chromosome into
segments ranging from 600 k to 1 Mb. Then a set of 30
reference values is created by averaging the percentage
of mapped reads attributable to each segment in a series
of euploid samples. The percentage of reads derived
from a given chromosome segment longer than 10 Mb
for an embryo (test) sample was divided by the reference
value for the same segment. The CNVs larger than 4
megabase (>4 M) would be truly detected actually.
Chromosomal duplication were associated with ratios >1.25
and deletion with ratios <0.75 [18].
Fluorescence in situ hybridization (FISH)
Chromosome analysis was done using a Carl Zeiss AXIO
microscope (Germany) with image analysis system
(CytoVision Leica). Fluorescence in situ hybridization
(FISH) was performed according to the previously pub-
lished protocols [19]. Commercially available probes
(Abbott Molecular) like Tel 4q, Tel 6p, Tel 9p, Tel 9q,
LSI 13 and CEP4 were used.
Multiplex ligation-dependent probe amplification (MLPA)
MLPA was performed using SALSA MLPA P036-E2 kit
(MRC-Holland). For each MLPA assay, 100 ng of DNA
was used following the manufacturer’s protocols. This
P036-E2 Subtelomeres mix 1 probemix contains one
MLPA probe for each subtelomeric region and is de-




The patient received transfer of normal embryo as indi-
cated by array CGH PGS (Fig. 1a). However, the preg-
nancy test was negative. The MLPA result showed that
the 9p probe was duplicated, and the 13q probe was de-
leted in the fifth abortion sample (Fig. 1b). The DNA
sample for array CGH assay was reanalyzed by NGS, which
revealed 46,XY.ngs [GRCh37/hg19] 9p24.3-9p24.1(10,291-
8,680,890×1), 13q33.1-13q34(103,046,327-114,785,444×3)
(Fig. 1c). G banding karyotyping of 550 bands also
showed no obvious structural abnormality (Fig. 1d).
FISH analysis with Tel 9p, Tel 9q and LSI 13 probes
confirmed the existence of the reciprocal translocation
in the male chromosome as 46,XY,t(9;13)(p24.1;q33.1).
(Figure 1e).
Case 2
The array CGH PGS results showed normal (Fig. 2a) but
the NGS result of the same sample was 46,XY.ngs
4q34.3-4q35.2(179,673,982-191,016,503×3), 6p25.3-6p22.3
(146,672-17,829,693×1), (Fig. 2b). To clarify the discrep-
ancy, result of array CGH for the second abortion product
was found to be 46,XY.arr 4q34.3-q35.2 (179,554,876-
190,864,789) × 3, 6p25.3-p22.3(347,038-17,543,199) × 1
(Fig. 2c,d). Further G banding karyotyping of 550
bands showed 46,XX,t(4;6)(q34.3;p22.3) of the female
(Fig. 2e). Tel 4q, CEP4 and Tel 6p three FISH probes
further verify the existence of the reciprocal trans-
location of female chromosome (Fig. 2f ) (Table 1).
Discussion
It was found that about 15 % of the RIF patients had
chromosome abnormalities, including chromosomal
translocation, inversion and mosaic [20]. Most of these
structural abnormalities can be revealed by routine
karyotyping. Because of the low resolution, many small
chromosome structural abnormalities of peripheral
blood cells cannot be detected in the routine karyotyp-
ing. Indeed, in the present study both couple had not
found obvious structural abnormality in routine karyo-
typing even they had RIF and RM.
In the first case, transfer of normal embryo after array
CGH PGS did not result in pregnancy and the MLPA re-
sult of the fifth abortion tissues showed abnormal
chromosome. NGS was applied to reanalyze the same
WGA sample of the embryo and small segmental trans-
locations were revealed. FISH assay of the couple’ per-
ipheral blood cells confirmed there were small
segmental translocations in the male. It is concluded
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that PGS by array CGH failed to detect small segmental
translocations, which may be responsible for RIF.
Lesson learned from case 1 urged us to reanalyze em-
bryos of case 2 before transplantation using NGS even
array CGH showed euploid. PGS by NGS showed that
one embryo was 46,XY.ngs 4q34.3-4q35.2(179,673,982-
191,016,503×3), 6p25.3-6p22.3 (146,672-17,829,693×1).
The result was confirmed by array CGH analysis of the
second abortion sample and FISH of the peripheral
blood cells of the couple, which revealed small segmen-
tal translocations of the female. We therefore abandoned
the embryo to avoid potential miscarriage after embryo
transfer.
Genetic test is very important for patients with RIF
and RM. Analysis of the abortion tissue samples with
more sensitive methods (such as high resolution
Fig. 1 Case 1. 1a: PGS profile of array CGH was normal; 1b: The MLPA result of the fifth abortion sample was 9p+,13q-; 1c: The NGS result was
46,XY.ngs[GRCh37/hg19] 9p24.3-9p24.1(10,291-8,680,890×1),13q33.1-13q34(103,046,327-114,785,444×3) (indicated by red circle); 1d: The G banding
karyotyping of 550 bands showed no obvious structural abnormality; 1e: FISH showed reciprocal translocation in the male chromosome. Tel 9p: green;
Tel 9q: orange; LSI 13 (RB1): orange
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Fig. 2 Case 2. 2a: PGS profile by array CGH was normal; 2b: PGS by NGS was 46,XY.ngs 4q34.3-4q35.2(179,673,982-191,016,503×3), 6p25.3-6p22.3
(146,672-17,829,693×1) (indicated by red circle); 2c, 2d: The array CGH result of the second abortion sample was arr 4q34.3-q35.2 (179,554,876-
190,864,789) × 3, 6p25.3-p22.3(347,038-17,543,199) × 1; 2e: The G banding karyotyping of 550 bands showed 46,XX,t(4; 6)(q34.3;p22.3); 2f: FISH
showed reciprocal translocation of female chromosome. Tel 4q: orange; CEP4: Aqua; Tel 6p: green
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karyotyping, FISH, MLPA, array CGH and NGS) to
identify small abnormal fragments of chromosomes is
necessary in addition to the traditional karyotyping. Fior-
entino et al reported [21] that the minimal fragment de-
tected by NGS was 14 Mb in PGS. Here we detected an
8.27 Mb abnormal fragment. Whether smaller fragment
can be detected deserves further study. In addition, Tan
et al reported [11] that among the chromosomally ab-
normal blastocysts subjected to both NGS and SNP
array tests, 7 blastocysts gave inconsistent results, which
were further validated by qPCR. All the qPCR signals
were in accordance with NGS. Here we found there was
discordance (abnormal vs normal) between NGS and
array CGH for the same WGA sample for the first time
on clinical PGS cycles. As expected, the NGS result was
supported by other tests and was therefore considered
to be correct.
Any testing has to balance the benefits of identifying
euploid embryos with the potential costs. Now the NGS
used here can truly detect the small segment larger than
4 megabase (>4 M) and the cost of sequencing was
already competitive with array tests, the whole reagent
cost of sequencing for WGA sample of the embryo was
currently less than $200. We have reasons to believe that
eventually the advantages of NGS will be brought to
PGS patients and widely used in the clinical practice.
Conclusions
In summary, sometimes the patients with small segmen-
tal translocations actually had not found obvious struc-
tural abnormality in routine karyotyping even they had
RIF and RM, and the currently available commercial
array CGH used for aneuploidy screening in PGS for
these patients with RIF and RM sometimes failed to de-
tect small segmental translocations. In our study we
found the NGS approach was effective in characterizing
small abnormal chromosomal fragments. It was a reli-
able alternative to array CGH to be used for PGS to
avoid failure of detection of small abnormal chromo-
somal fragments in patients with RIF and RM.
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